| J2350 | Injection, ocrelizumab, 1 mg | 7,200 | $50 | $338.4K |
| J3032 | Injection, eptinezumab-jjmr, 1 mg | 12,300 | $10 | $159.9K |
| J0585 | Injection, onabotulinumtoxina, 1 unit | 28,090 | $10 | $140.4K |
| J0588 | Injection, incobotulinumtoxin a, 1 unit | 14,520 | $1 | $58.1K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 490 | $80 | $38.6K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 350 | $50 | $17.4K |
| 64615 | The provider bilaterally administers a chemical compound to the muscles innervated by the trigeminal, facial, cervical spinal, and accessory nerves. The goal of this procedure is to paralyze the… | 140 | $100 | $14.2K |
| 99204 | The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the provider… | 100 | $120 | $12K |
| 99490 | The clinical staff provides services directed by the provider to support and coordinate a patient’s care across multiple disciplines. The patient has two or more chronic conditions that place the… | 250 | $50 | $11.2K |
| 70551 | The provider uses magnetic resonance imaging, or MRI, to examine the brain and brain stem. The provider does not administer contrast for this exam. | 70 | $90 | $6.1K |